Chemical Properties:
Package: Fluorinated Bottle, 25kg/Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Olmesartan Medoxomil Intermediates With High Quality: 4,5-Dimethyl-1,3-Dioxol-2-One (DMDO) CAS 37830-90-3 4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7 Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0 Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1 Trityl Olmesartan Ethyl Ester CAS 144690-33-5 Trityl Olmesartan Acid CAS 761404-85-7 N2-Trityl Olmesartan Acid CAS 752179-89-8 Trityl Olmesartan Medoxomil CAS 144690-92-6 Olmesartan Medoxomil CAS 144689-63-4| Item | Specifications |
| Appearance | Colorless to Yellow Liquid |
| Identification (GC) | The retention time of the major peak in the chromatogram of the sample corresponds ti that of the standard as obtained in purity and related substances |
| Purity / Analysis Method | >96.0% (GC) |
| Water (by Karl Fischer) | <0.50% |
| Impurity A | <1.50% |
| Impurity B | <0.50% |
| Impurity C | <3.00% |
| Impurity D | <4.00% |
| Impurity E | <0.10% |
| Refractive Index N20/D | 1.476~1.482 |
| Specific Gravity (20/20℃) | 1.357~1.363 |
| Proton NMR Spectrum | Conforms to Structure |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Olmesartan Medoxomil (CAS: 144689-63-4) |
Description:
Specifications:
Package & Storage:
| Chemical Name | 4-Chloromethyl-5-methyl-1,3-dioxol-2-one |
| Synonyms | DMDO-Cl |
| CAS Number | 80841-78-7 |
| CAT Number | RF-PI1871 |
| Stock Status | In Stock, Production Capacity 300 Tons/Year |
| Molecular Formula | C5H5ClO3 |
| Molecular Weight | 148.54 |
| Boiling Point | 93℃/2 mmHg |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
4-Chloromethyl-5-methyl-1,3-dioxol-2-one, (DMDO-Cl) (CAS: 80841-78-7) is an intermediate of Olmesartan Medoxomil (CAS: 144689-63-4. Olmesartan Medoxomil is a new selective and competitive nonpeptide angiotensin II receptor antagonist used to treat high blood pressure. Olmesartan works by blocking the binding of angiotensin II to the AT1 receptors in vascular muscle. By blocking the binding rather than the synthesis of angiotensin II, olmesartan inhibits the negative regulatory feedback on renin secretion. Olmesartan Medoxomil was launched in the US as Benicar@, an orally administered treatment for hypertension.
